Big earnings such as Robinhood, Shopify and AppLovin, along with inflation reports, are potential market headwinds.

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while revenue slightly missed estimates.

Amazon (AMZN) stock is pulling back, after a better-than-expected fourth quarter was overshadowed by a weak forecast ...

Operator Greetings, and welcome to the Proto Labs fourth quarter and fiscal year 2024 earnings call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow ...

While its ad segment’s rate of growth cooled in Q4 compared to the year-ago period, Amazon has successfully won over more non ...